Q4 2015 13F Holders as of 12/31/2015
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
174M
-
Number of holders
-
17
-
Total 13F shares, excl. options
-
13.8M
-
Shares change
-
+5.29M
-
Total reported value, excl. options
-
$219M
-
Value change
-
+$83.2M
-
Number of buys
-
15
-
Price
-
$15.95
Significant Holders of Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share (WVE) as of Q4 2015
17 filings reported holding WVE - Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share as of Q4 2015.
Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share (WVE) has 17 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.8M shares
of 174M outstanding shares and own 7.91% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, LLC (7.09M shares), FMR LLC (2.06M shares), Foresite Capital Management III, LLC (1.41M shares), Redmile Group, LLC (1.21M shares), New Leaf Venture Partners, L.L.C. (784K shares), Clough Capital Partners L P (393K shares), Cormorant Asset Management, LLC (392K shares), JENNISON ASSOCIATES LLC (369K shares), GEODE CAPITAL MANAGEMENT, LLC (38.7K shares), and GOLDMAN SACHS GROUP INC (13.9K shares).
This table shows the top 17 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.